GO:0035607

BP

fibroblast growth factor receptor signaling pathway involved in orbitofrontal cortex development

The series of molecular signals generated as a consequence of a fibroblast growth factor-type receptor binding to one of its physiological ligands, which contributes to the progression of the orbitofrontal cortex over time from its initial formation until its mature state.

FGFR1, FGFR2

GO:0035609

BP

C-terminal protein deglutamylation

The removal of a C-terminal, gene-encoded glutamate residue from a protein.

AGBL1, AGTPBP1

GO:0035610

BP

protein side chain deglutamylation

The removal of a glutamate residue from the side chain of a protein. Glutamate side chains are added to glutamic acid residues within the primary protein sequence during polyglutamylation.

AGBL1, AGTPBP1

GO:0035616

BP

histone H2B conserved C-terminal lysine deubiquitination

A histone deubiquitination process in which a ubiquitin monomer is removed from a conserved lysine residue in the C-terminus of histone H2B. The conserved lysine residue is K119 in fission yeast, K123 in budding yeast, or K120 in mammals.

USP15

GO:0035622

BP

intrahepatic bile duct development

The progression of the intrahepatic bile ducts over time, from their formation to the mature structure. Intrahepatic bile ducts (bile ducts within the liver) collect bile from bile canaliculi in the liver, and connect to the extrahepatic bile ducts (bile ducts outside the liver).

SOX9

GO:0035623

BP

renal glucose absorption

A renal system process in which glucose is taken up from the collecting ducts and proximal and distal loops of the nephron. In non-mammalian species, absorption may occur in related structures.

HNF1A

GO:0035624

BP

receptor transactivation

The process in which a receptor is activated by another receptor. Receptor transactivation can occur through different mechanisms and includes cross-talk between signaling pathways where one receptor activates a receptor for a different ligand, and also activation of subunits within a receptor oligomer.

NCOA3

GO:0035625

BP

epidermal growth factor-activated receptor transactivation by G-protein coupled receptor signaling pathway

The process in which an epidermal growth factor-activated receptor is activated via signaling events from a G-protein coupled receptor. This is an example of cross-talk between the EGF and GPCR signaling pathways.

ADRA2B, ADAM17

GO:0035630

BP

bone mineralization involved in bone maturation

The deposition of hydroxyapatite, involved in the progression of the skeleton from its formation to its mature state.

IGF1, BMP2, LEP, ANO6

GO:0035633

BP

maintenance of blood-brain barrier

Preserving the permeability barrier between the blood and the brain in a stable functional or structural state. The cells in the brain are packed tightly together preventing the passage of most molecules from the blood into the brain. Only lipid soluble molecules or those that are actively transported can pass through the blood-brain barrier.

PTGS2

GO:0035634

BP

response to stilbenoid

Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of exposure to a stilbenoid. Stilbenoids are secondary products of heartwood formation in trees that can act as phytoalexins. Stilbenoids are hydroxylated derivatives of stilbene. They belong to the family of phenylpropanoids and share most of their biosynthesis pathway with chalcones.

CD36

GO:0035640

BP

exploration behavior

The specific behavior of an organism in response to a novel environment or stimulus.

CHL1, ITGA3, AGTR2, ABAT

GO:0035641

BP

locomotory exploration behavior

The specific movement from place to place of an organism in response to a novel environment.

PENK, DPP4, DLG4, LSAMP, TNR

GO:0035644

BP

phosphoanandamide dephosphorylation

The process of removing one or more phosphate groups from a phosphorylated anandamide.

PTPN22

GO:0035646

BP

endosome to melanosome transport

The directed movement of substances from endosomes to the melanosome, a specialised lysosome-related organelle.

AP3D1, RAB32, BLOC1S3, ANKRD27, BLOC1S6

GO:0035655

BP

interleukin-18-mediated signaling pathway

A series of molecular signals initiated by the binding of interleukin-18 to a receptor on the surface of a cell, and ending with regulation of a downstream cellular process, e.g. transcription.

PDGFB, AKT1, IL18R1, IL18

GO:0035665

BP

TIRAP-dependent toll-like receptor 4 signaling pathway

Any series of molecular signals generated as a consequence of binding to a toll-like receptor 4 where the TIRAP/MAL adaptor mediates transduction of the signal. Toll-like 4 receptors are pattern recognition receptors that bind bacterial lipopolysaccharide (LPS) to initiate an innate immune response.

TIRAP

GO:0035666

BP

TRIF-dependent toll-like receptor signaling pathway

Any series of molecular signals generated as a consequence of binding to a toll-like receptor where the TRIF adaptor mediates transduction of the signal. Toll-like receptors directly bind pattern motifs from a variety of microbial sources to initiate innate immune response.

TLR4, TLR3, CD14, UBC, UBE2D3, RPS27A, UBA52, FADD, BIRC3, RIPK1, CASP8, TANK, TBK1

GO:0035672

BP

oligopeptide transmembrane transport

The directed movement of an oligopeptide across a membrane by means of some agent such as a transporter or pore. Oligopeptides are molecules that contain a small number (2 to 20) of amino-acid residues connected by peptide linkages.

CDH17

GO:0035674

BP

tricarboxylic acid transmembrane transport

The process in which tricarboxylic acids are transported from one side of a membrane to the other by means of some agent such as a transporter or pore.

SLC25A1

GO:0035684

BP

helper T cell extravasation

The migration of a helper T cell from the blood vessels into the surrounding tissue. A helper T-cell is an effector T cell that provides help in the form of secreted cytokines to other immune cells.

CCL2

GO:0035690

BP

cellular response to drug

Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a drug stimulus. A drug is a substance used in the diagnosis, treatment or prevention of a disease.

PPP1R12A, TLR3, EGFR, MYC, IL1B, TFRC, MT2A, PRNP, TP53, EDN1, TH, HSP90AB1, QDPR, FBP1, RAP2A, UMPS, CCL4, CCL2, NME1, MT3, CAD, PPM1F, PRKAA2, RAP1A, GPLD1, PPAT, MEF2C, PPP3CA, KCNH2, EIF2B5, GAS6, ANKRD1, ADIPOQ, ADSSL1, RNF149, PPM1E, PPP1R14A, RBM22

GO:0035691

BP

macrophage migration inhibitory factor signaling pathway

A series of molecular signals initiated by the binding of macrophage migration inhibitory factor to a receptor on the surface of a cell, and ending with regulation of a downstream cellular process, e.g. transcription.

CD74

GO:0035694

BP

mitochondrial protein catabolic process

The chemical reactions and pathways resulting in the breakdown of a mitochondrial protein. This process is necessary to maintain the healthy state of mitochondria and is thought to occur via the induction of an intramitochondrial lysosome-like organelle that acts to eliminate the damaged oxidised mitochondrial proteins without destroying the mitochondrial structure.

BNIP3L, BNIP3, SPATA18, YME1L1

GO:0035695

BP

mitophagy by induced vacuole formation

The process in which cells degrade mitochondria by inducing a vacuole-like structure which directly engulfs and degrades the unhealthy mitochondria by accumulating lysosomes.

SPATA18

GO:0035701

BP

hematopoietic stem cell migration

The orderly movement of a hematopoietic stem cell from one site to another. A hematopoietic stem cell is a cell from which all cells of the lymphoid and myeloid lineages develop, including blood cells and cells of the immune system.

KIT, GPLD1

GO:0035709

BP

memory T cell activation

The change in morphology and behavior of a memory T cell resulting from exposure to a mitogen, cytokine, chemokine, cellular ligand, or an antigen for which it is specific.

TNFSF4

GO:0035711

BP

T-helper 1 cell activation

The change in morphology and behavior of a T-helper 1 cell resulting from exposure to a mitogen, cytokine, chemokine, cellular ligand, or an antigen for which it is specific.

HMGB1, CEBPB

GO:0035712

BP

T-helper 2 cell activation

The change in morphology and behavior of a T helper 2 cell resulting from exposure to a mitogen, cytokine, chemokine, cellular ligand, or an antigen for which it is specific.

TNFSF4

GO:0035713

BP

response to nitrogen dioxide

Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a nitrogen dioxide (NO2) stimulus.

TNFSF4

GO:0035714

BP

cellular response to nitrogen dioxide

Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a nitrogen dioxide (NO2) stimulus.

TNFSF4

GO:0035720

BP

intraciliary anterograde transport

The directed movement of large protein complexes along microtubules from the cell body toward the tip of a cilium (also called flagellum), mediated by motor proteins.

IFT122

GO:0035721

BP

intraciliary retrograde transport

The directed movement of large protein complexes along microtubules from the tip of a cilium (also called flagellum) toward the cell body, mediated by motor proteins.

IFT43, IFT122, WDR35

GO:0035722

BP

interleukin-12-mediated signaling pathway

A series of molecular signals initiated by the binding of interleukin-12 to a receptor on the surface of a cell, and ending with regulation of a downstream cellular process, e.g. transcription.

JAK2, IL12RB1, PLCB1

GO:0035723

BP

interleukin-15-mediated signaling pathway

A series of molecular signals initiated by the binding of interleukin-15 to a receptor on the surface of a cell, and ending with regulation of a downstream cellular process, e.g. transcription.

PLCB1

GO:0035725

BP

sodium ion transmembrane transport

A process in which a sodium ion is transported from one side of a membrane to the other by means of some agent such as a transporter or pore.

KCNK1, SLC3A2, SCNN1A, SLC6A8, TRAPPC10, SCNN1G, SLC20A2, PKD2, SHROOM2, SCN9A, ASIC2, ANO6, TRPM4, SLC20A1, SLC5A5, SLC24A3, SLC23A2, ASIC3, SLC4A4

GO:0035726

BP

common myeloid progenitor cell proliferation

The multiplication or reproduction of common myeloid progenitor cells, resulting in the expansion of a cell population. A common myeloid progenitor cell is a progenitor cell committed to the myeloid lineage.

GSTP1, NR4A3

GO:0035729

BP

cellular response to hepatocyte growth factor stimulus

Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a hepatocyte growth factor stimulus.

NRP1, IL6, TDGF1, HGF, CREB1, IL10, GCLC, GCLM, GSK3B, RELA, SIRT2

GO:0035732

BP

nitric oxide storage

The accumulation and maintenance in cells or tissues of nitric oxide (NO). Nitric oxide is stored in the form of dinitrosyl-iron complexes, which are stabilized, and possibly sequestered, by binding to glutathione S-transferase proteins.

GSTP1

GO:0035733

BP

hepatic stellate cell activation

A change in the morphology or behavior of a hepatic stellate cell resulting from exposure to a cytokine, chemokine, hormone, cellular ligand or soluble factor.

GCLM

GO:0035735

BP

intraciliary transport involved in cilium morphogenesis

The bidirectional movement of large protein complexes along microtubules within a cilium that contributes to cilium morphogenesis.

PCM1, IFT81, IFT74, IFT122, SSX2IP

GO:0035743

BP

CD4-positive, alpha-beta T cell cytokine production

Any process that contributes to cytokine production by a CD4-positive, alpha-beta T cell.

CD55

GO:0035747

BP

natural killer cell chemotaxis

The directed movement of a natural killer cell guided by a specific chemical concentration gradient. Movement may be towards a higher concentration (positive chemotaxis) or towards a lower concentration (negative chemotaxis).

PIK3CD, PIK3CG

GO:0035750

BP

protein localization to myelin sheath abaxonal region

Any process in which a protein is transported to, and/or maintained in, the abaxonal region of the myelin sheath. The abaxonal region is the region of the myelin sheath furthest from the axon.

MPP5

GO:0035751

BP

regulation of lysosomal lumen pH

Any process that modulates the pH of the lysosomal lumen, measured by the concentration of the hydrogen ion.

TMEM165

GO:0035752

BP

lysosomal lumen pH elevation

Any process that increases the pH of the lysosomal lumen, measured by the concentration of the hydrogen ion.

CLN3

GO:0035754

BP

B cell chemotaxis

The directed movement of a B cell guided by a specific chemical concentration gradient. Movement may be towards a higher concentration (positive chemotaxis) or towards a lower concentration (negative chemotaxis).

PIK3CD, CH25H, GAS6, HSD3B7

GO:0035767

BP

endothelial cell chemotaxis

The directed movement of an endothelial cell guided by a specific chemical concentration gradient. Movement may be towards a higher concentration (positive chemotaxis) or towards a lower concentration (negative chemotaxis).

NRP1, PLEKHG5, VEGFA, NR4A1, EGR3, CORO1B

GO:0035771

BP

interleukin-4-mediated signaling pathway

A series of molecular signals initiated by the binding of interleukin-4 to a receptor on the surface of a cell, and ending with regulation of a downstream cellular process, e.g. transcription.

IL4R, JAK3

GO:0035773

BP

insulin secretion involved in cellular response to glucose stimulus

The regulated release of proinsulin from secretory granules (B granules) in the B cells of the pancreas; accompanied by cleavage of proinsulin to form mature insulin, in response to a glucose stimulus.

RAF1, RAB11B, RAB11FIP2

GO:0035774

BP

positive regulation of insulin secretion involved in cellular response to glucose stimulus

Any process that increases the frequency, rate or extent of the regulated release of insulin that contributes to the response of a cell to glucose.

GCG, CFTR, SRI, OXCT1, GPLD1, STX4, HIF1A, TRPM4, BAD, NR1H4, PHPT1, GPR27

GO:0035783

BP

CD4-positive, alpha-beta T cell costimulation

The process of providing, via surface-bound receptor-ligand pairs, a second, antigen-independent, signal in addition to that provided by the T cell receptor to augment CD4-positive, alpha-beta T cell activation.

TNFSF4

GO:0035789

BP

metanephric mesenchymal cell migration

The orderly movement of undifferentiated metanephric mesenchymal cells (precursors to metanephric mesangial cells) from the mesenchyme into the cleft of the developing glomerulus, during development of the metanephros.

PDGFRB

GO:0035790

BP

platelet-derived growth factor receptor-alpha signaling pathway

A series of molecular signals initiated by the binding of a ligand to an alpha-type platelet-derived growth factor receptor (PDGFalpha) on the surface of a signal-receiving cell, and ending with regulation of a downstream cellular process, e.g. transcription.

PDGFRA

GO:0035791

BP

platelet-derived growth factor receptor-beta signaling pathway

A series of molecular signals initiated by the binding of a ligand to a beta-type platelet-derived growth factor receptor (PDGFbeta) on the surface of a signal-receiving cell, and ending with regulation of a downstream cellular process, e.g. transcription.

PDGFRB

GO:0035793

BP

positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway

Any process that increases the frequency, rate or extent of metanephric mesenchymal cell migration as a result of the series of molecular signals generated as a consequence of a platelet-derived growth factor receptor-beta binding to one of its physiological ligands.

PDGFB, PDGFA, PDGFRB

GO:0035794

BP

positive regulation of mitochondrial membrane permeability

Any process that increases the frequency, rate or extent of the passage or uptake of molecules by the mitochondrial membrane.

HEBP2

GO:0035799

BP

ureter maturation

A developmental process, independent of morphogenetic (shape) change, that is required for the ureter to attain its fully functional state. The ureter is a muscular tube that transports urine from the kidney to the urinary bladder or from the Malpighian tubule to the hindgut.

ALDH1A2

GO:0035802

BP

adrenal cortex formation

The process that gives rise to the adrenal cortex. This process pertains to the initial formation of a structure from unspecified parts. The adrenogonadal primordium from which the adrenal cortex is formed derives from a condensation of coelomic epithelial cells (the urogenital ridge; the same structure from which gonads and kidney also originate).

WT1, CITED2

GO:0035803

BP

egg coat formation

Construction of an egg coat, a specialized extracellular matrix that surrounds the ovum of animals. The egg coat provides structural support and can play an essential role in oogenesis, fertilization and early development.

ZP3

GO:0035810

BP

positive regulation of urine volume

Any process that increases the amount of urine excreted from the body over a unit of time.

EDN1, DRD2, NPPB, NPR3, BTC, OPRL1, HYAL2, HAS2, INPP5K

GO:0035811

BP

negative regulation of urine volume

Any process that decreases the amount of urine excreted from the body over a unit of time.

AVPR2

GO:0035813

BP

regulation of renal sodium excretion

Any process that modulates the amount of sodium excreted in urine over a unit of time.

AGT, AGTR1

GO:0035814

BP

negative regulation of renal sodium excretion

Any process that decreases the amount of sodium excreted in urine over a unit of time.

COMT, AVPR2, ADORA1, SPX

GO:0035815

BP

positive regulation of renal sodium excretion

Any process that increases the amount of sodium excreted in urine over a unit of time.

AGT, EDN1, DRD2, NPPB, AGTR2

GO:0035822

BP

gene conversion

A DNA recombination process that results in the unidirectional transfer of genetic material from a donor sequence to a highly homologous acceptor.

NUCKS1

GO:0035844

BP

cloaca development

The process whose specific outcome is the progression of the cloaca over time, from it's formation to the mature structure. The cloaca is the common chamber into which intestinal, genital and urinary canals open in vertebrates.

AHI1

GO:0035845

BP

photoreceptor cell outer segment organization

A process that is carried out at the cellular level and results in the assembly, arrangement of constituent parts, or disassembly of the outer segment of a photoreceptor cell, a sensory cell that reacts to the presence of light. The outer segment of the photoreceptor cell contains the light-absorbing materials.

AHI1

GO:0035855

BP

megakaryocyte development

The process whose specific outcome is the progression of a megakaryocyte cell over time, from its formation to the mature structure. Megakaryocyte development does not include the steps involved in committing a cell to a megakaryocyte fate. A megakaryocyte is a giant cell 50 to 100 micron in diameter, with a greatly lobulated nucleus, found in the bone marrow.

MEIS1, KIT, TAL1, PTPN11, EP300, ABI1, WASF2

GO:0035860

BP

glial cell-derived neurotrophic factor receptor signaling pathway

The series of molecular signals generated as a consequence of a glial cell-derived neurotrophic factor receptor binding to one of its physiological ligands.

SULF2, SULF1

GO:0035863

BP

dITP catabolic process

The chemical reactions and pathways resulting in the breakdown of dITP, a deoxyinosine phosphate compound having a triphosphate group at the 5'-position.

NUDT16

GO:0035864

BP

response to potassium ion

Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a potassium ion stimulus.

GNRH1

GO:0035865

BP

cellular response to potassium ion

Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a potassium ion stimulus.

CYP11B1, CYP11B2, HSF1, PPARGC1A

GO:0035871

BP

protein K11-linked deubiquitination

A protein deubiquitination process in which a K11-linked ubiquitin chain, i.e. a polymer of ubiquitin formed by linkages between lysine residues at position 11 of the ubiquitin monomers, is removed from a protein.

TNFAIP3, OTUD7B, OTUB2, VCPIP1

GO:0035873

BP

lactate transmembrane transport

The directed movement of lactate across a membrane by means of some agent such as a transporter or pore. Lactate is 2-hydroxypropanoate, CH3-CHOH-COOH; L(+)-lactate is formed by anaerobic glycolysis in animal tissues, and DL-lactate is found in sour milk, molasses and certain fruit juices.

SLC16A7

GO:0035878

BP

nail development

The process whose specific outcome is the progression of a nail over time, from its formation to the mature structure. A nail is a horn-like envelope covering the outer end of a finger or toe, and consists of the nail plate, the nail matrix and the nail bed below it, and the grooves surrounding it.

ITGB4, ITGA6

GO:0035879

BP

plasma membrane lactate transport

The directed movement of lactate across a plasma membrane.

SLC16A6, SLC16A3, SLC16A7, SLC16A12

GO:0035880

BP

embryonic nail plate morphogenesis

The process, occurring in the embryo, by which the anatomical structures of a nail plate are generated and organized. The nail plate is the hard and translucent portion of the nail, composed of keratin, and serves to protect the tips of digits.

FZD6

GO:0035886

BP

vascular smooth muscle cell differentiation

The process in which a relatively unspecialized cell acquires specialized features of a vascular smooth muscle cell.

PITX2, EPC1

GO:0035897

BP

proteolysis in other organism

The chemical reactions and pathways performed by an organism resulting in the hydrolysis of proteins in another organism by cleavage of their peptide bonds.

MAP2K7, MAP2K2, MAP2K6, MAP2K1

GO:0035900

BP

response to isolation stress

Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a lack of contact with other members of the same species.

TH, NAPEPLD

GO:0035902

BP

response to immobilization stress

Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of being rendered immobile.

FOS, TGFB1, CYP1A1, GPI, TH, GAL, PPARG, HNMT, NR0B1

GO:0035904

BP

aorta development

The progression of the aorta over time, from its initial formation to the mature structure. An aorta is an artery that carries blood from the heart to other parts of the body.

SMAD6, LOX, NDST1, AP2B1, LRP2, LOXL1, PKD2, LTBP1, TAB1, PRICKLE1, DCTN5, ADAMTS6, SUFU, PLXND1

GO:0035909

BP

aorta morphogenesis

The process in which the anatomical structures of an aorta are generated and organized. An aorta is an artery that carries blood from the heart to other parts of the body.

TBX1, PDGFRB, JAG1, NPRL3, CHD7

GO:0035910

BP

ascending aorta morphogenesis

The process in which the anatomical structures of the ascending aorta are generated and organized. The ascending aorta is the portion of the aorta in a two-pass circulatory system that lies between the heart and the arch of aorta. In a two-pass circulatory system blood passes twice through the heart to supply the body once.

TGFB2, SOX4, HES1

GO:0035912

BP

dorsal aorta morphogenesis

The process in which the anatomical structures of the dorsal aorta are generated and organized. The dorsal aorta is a blood vessel in a single-pass circulatory system that carries oxygenated blood from the gills to the rest of the body. In a single-pass circulatory system blood passes once through the heart to supply the body once.

BMPR1A, DLL4, HEY1

GO:0035914

BP

skeletal muscle cell differentiation

The process in which a relatively unspecialized cell acquires specialized features of a skeletal muscle cell, a somatic cell located in skeletal muscle.

NUPR1, FOS, RB1, EGR2, EEF2, EGR1, ATF3, FOXN2, NOTCH1, EMD, SOX8, BTG2, MEF2C, MEF2D, ANKRD1, HLF, HIVEP3, ZNF689, HEYL, HMG20B, MAFF, PLAGL1

GO:0035921

BP

desmosome disassembly

The controlled breakdown of a desmosome. A desmosome is a patch-like intercellular junction found in vertebrate tissues, consisting of parallel zones of two cell membranes, separated by an space of 25-35 nm, and having dense fibrillar plaques in the subjacent cytoplasm.

SNAI2

GO:0035922

BP

foramen ovale closure

The morphogenetic process in which the foramen ovale closes after birth, to prevent blood flow between the right and left atria. In the fetal heart, the foramen ovale allows blood to enter the left atrium from the right atrium. Closure of the foramen ovale after birth stops this blood flow.

GJA5

GO:0035924

BP

cellular response to vascular endothelial growth factor stimulus

Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a vascular endothelial growth factor stimulus.

ITGB1BP1, NRP1, ERN1, HSPB1, MT1G, VEGFA, VCAM1, NR4A1, AKT1, FLT4, NOTCH1, MAPKAPK2, GAS1, EGR3, PRKD1, MAPK14, PRKD2, DLL4

GO:0035926

BP

chemokine (C-C motif) ligand 2 secretion

The regulated release of chemokine (C-C motif) ligand 2 (CCL2) from a cell.

F2RL1, FOXP1

GO:0035927

BP

RNA import into mitochondrion

The directed movement of RNA from the cytoplasm into a mitochondrion.

PNPT1

GO:0035928

BP

rRNA import into mitochondrion

The directed movement of rRNA, ribosomal ribonucleic acid, from the cytoplasm into a mitochondrion.

PNPT1

GO:0035932

BP

aldosterone secretion

The regulated release of aldosterone into the circulatory system. Aldosterone is a pregnane-based steroid hormone produced by the outer-section (zona glomerulosa) of the adrenal cortex in the adrenal gland, and acts on the distal tubules and collecting ducts of the kidney to cause the conservation of sodium, secretion of potassium, increased water retention, and increased blood pressure. The overall effect of aldosterone is to increase reabsorption of ions and water in the kidney.

AGTR2

GO:0035945

BP

mitochondrial ncRNA surveillance

The set of processes involved in identifying and degrading defective or aberrant non-coding RNA transcripts (ncRNAs) within the mitochondrion.

SUPV3L1

GO:0035946

BP

mitochondrial mRNA surveillance

The set of processes involved in identifying and degrading messenger RNA (mRNA) within the mitochondrion.

SUPV3L1

GO:0035947

BP

regulation of gluconeogenesis by regulation of transcription from RNA polymerase II promoter

Any process that modulates the frequency, rate or extent of gluconeogenesis, by regulation of transcription from an RNA polymerase II promoter.

NR1D1, FOXO1

GO:0035948

BP

positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter

Any process that activates or increases the frequency, rate or extent of gluconeogenesis by activating or increasing the frequency, rate or extent of transcription from an RNA polymerase II promoter.

GCG, KAT2B

GO:0035963

BP

cellular response to interleukin-13

Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an interleukin-13 stimulus.

ALOX15, SHPK

GO:0035964

BP

COPI-coated vesicle budding

The evagination of a Golgi membrane, resulting in formation of a COPI-coated vesicle.

TMED10